BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Blue Cap AG annonce un exercice financier 2025 réussi Amélioration De L'EBITDA Résultats Financiers 2025 Prévisions Pour 2026 Casquette Bleue AG Vente Con-Pearl
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Newron Pharmaceuticals Announces Board Nominee Changes Board Of Directors Annual General Meeting Newron Pharmaceuticals George Garibaldi Paolo Zocchi
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Newron Pharmaceuticals annonce des changements au sein de son conseil d'administration Conseil D'administration Assemblée Générale Annuelle Newron Pharmaceuticals George Garibaldi Paolo Zocchi
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Mersen Reports Resilient 2025 Performance, Projects Growth for 2026 Dividend Proposal Market Expansion 2026 Growth Forecast 2025 Performance Mersen Financial Results
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Performance de Mersen en 2025 et perspectives pour 2026 Investissements Résilience Financière Croissance 2026 Objectifs 2029 Performance 2025
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Groupe GORGE Achieves Strong Financial Performance in 2025 Revenue Growth Financial Performance Order Intake EBITDA Improvement Fundraising Efforts
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Le Groupe GORGE réalise de solides performances financières en 2025 Performance Financière Croissance Des Revenus Amélioration De L'EBITDA Prise De Commande Efforts De Collecte De Fonds
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3 FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Le venglustat de Sanofi obtient la désignation de thérapie innovante pour la maladie de Gaucher de type 3 FDA Sanofi Thérapie Révolutionnaire Venglustat Maladie De Gaucher
BRIEF published on 03/18/2026 at 07:05, 1 month 4 days ago Sanofi : Désignation de thérapie innovante pour le venglustat aux États-Unis FDA Sanofi Venglustat Maladie De Gaucher Découverte Médicale
Published on 04/22/2026 at 16:00, 2 hours 37 minutes ago Datavault AI Further Expands IP Portfolio with New Patent Issuance and Notices of Allowance
Published on 04/22/2026 at 15:15, 3 hours 22 minutes ago Karbon-X Highlights SkyXero on Earth Day, Bringing Real-Time Climate Action to Travel
Published on 04/22/2026 at 13:45, 4 hours 52 minutes ago Amarc Announces Listing on Frankfurt Stock Exchange
Published on 04/22/2026 at 13:30, 5 hours 7 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:30, 5 hours 7 minutes ago Copper Road Announces Engagement of George Mannard
Published on 04/22/2026 at 17:45, 51 minutes ago Readcrest Capital and KFK Holding to develop 1,000 Residential Units in Fürstenwalde near Berlin
Published on 04/22/2026 at 15:30, 3 hours 6 minutes ago Deutsche Postbank Funding Trust III - Annual Report 2025
Published on 04/22/2026 at 15:20, 3 hours 16 minutes ago Aurise Foundation Launches XAUE, Unlocking Yield for RWA Gold
Published on 04/22/2026 at 17:45, 52 minutes ago Cie du Bois Sauvage: Tijdens de Gewone en Buitengewone Algemene Vergaderingen van 22 april 2026 werden alle agendapunten goedgekeurd
Published on 04/22/2026 at 17:45, 52 minutes ago Air Liquide to invest over 350M USD to support steel industry and strengthen its footprint in Louisiana
Published on 04/22/2026 at 17:45, 52 minutes ago Cie du Bois Sauvage : Tous les points à l'ordre du jour des Assemblées Générales Ordinaire et Extraordinaire du 22 avril 2026 ont été approuvés
Published on 04/22/2026 at 17:45, 52 minutes ago Cie du Bois Sauvage: All agenda items of the Ordinary and Extraordinary General Meetings of April 22nd, 2026 have been approved
Published on 04/22/2026 at 17:45, 52 minutes ago Air Liquide va investir plus de 350 millions USD pour soutenir l'industrie sidérurgique et renforcer sa présence en Louisiane